Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

535 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Intraindividual Variability in Serial Lipoprotein(a) Concentrations Among Placebo-Treated Patients in the OCEAN(a)-DOSE Trial.
Gaba P, Rosenson RS, López JAG, Watts GF, Leucker TM, Kuder JF, Im K, Kassahun H, Wang H, Wu Y, Wang J, Ohman EM, Sabatine MS, O'Donoghue ML. Gaba P, et al. Among authors: sabatine ms. J Am Coll Cardiol. 2024 Dec 4:S0735-1097(24)10043-5. doi: 10.1016/j.jacc.2024.10.081. Online ahead of print. J Am Coll Cardiol. 2024. PMID: 39665702 Free article. No abstract available.
Sodium-glucose co-transporter 2 inhibitors and new-onset diabetes in cardiovascular or kidney disease.
Ostrominski JW, Højbjerg Lassen MC, Claggett BL, Miao ZM, Inzucchi SE, Docherty KF, Desai AS, Jhund PS, Køber L, Ponikowski P, Sabatine MS, Lam CSP, Martinez FA, de Boer RA, Hernandez AF, Shah SJ, Petersson M, Langkilde AM, McMurray JJV, Solomon SD, Vaduganathan M. Ostrominski JW, et al. Among authors: sabatine ms. Eur Heart J. 2024 Nov 21:ehae780. doi: 10.1093/eurheartj/ehae780. Online ahead of print. Eur Heart J. 2024. PMID: 39568016
Dapagliflozin in Heart Failure, Type 2 Diabetes, and Neuropathy: A Meta-Analysis of DAPA-HF and DELIVER.
Butt JH, Shen L, Inzucchi SE, Docherty KF, Jhund PS, Martinez FA, Sabatine MS, Vaduganathan M, Solomon SD, McMurray JJV; DAPA-HF and DELIVER Committees and Investigators. Butt JH, et al. Among authors: sabatine ms. JACC Heart Fail. 2024 Nov;12(11):1946-1948. doi: 10.1016/j.jchf.2024.07.017. Epub 2024 Sep 11. JACC Heart Fail. 2024. PMID: 39269393 No abstract available.
Clinical characteristics and outcomes of patients aged 80 years and over with heart failure: Need for better treatment.
Yang M, Kondo T, Anand IS, de Boer RA, Campbell RT, Køber L, Lam CSP, Maggioni AP, Martinez FA, O'Meara E, Packer M, Sabatine MS, Kerr Saraiva JF, Shah SJ, Zannad F, Zile MR, Jhund PS, Solomon SD, McMurray JJV. Yang M, et al. Among authors: sabatine ms. Eur J Heart Fail. 2024 Aug 21. doi: 10.1002/ejhf.3417. Online ahead of print. Eur J Heart Fail. 2024. PMID: 39169481
The Off-Treatment Effects of Olpasiran on Lipoprotein(a) Lowering: OCEAN(a)-DOSE Extension Period Results.
O'Donoghue ML, Rosenson RS, López JAG, Lepor NE, Baum SJ, Stout E, Gaudet D, Knusel B, Kuder JF, Murphy SA, Wang H, Wu Y, Shah T, Wang J, Wilmanski T, Sohn W, Kassahun H, Sabatine MS; OCEAN(a)-DOSE Trial Investigators. O'Donoghue ML, et al. Among authors: sabatine ms. J Am Coll Cardiol. 2024 Aug 27;84(9):790-797. doi: 10.1016/j.jacc.2024.05.058. J Am Coll Cardiol. 2024. PMID: 39168564 Free article. Clinical Trial.
Clonal hematopoiesis, cardiovascular events and treatment benefit in 63,700 individuals from five TIMI randomized trials.
Marston NA, Pirruccello JP, Melloni GEM, Kamanu F, Bonaca MP, Giugliano RP, Scirica BM, Wiviott SD, Bhatt DL, Steg PG, Raz I, Braunwald E, Libby P, Ellinor PT, Bick AG, Sabatine MS, Ruff CT. Marston NA, et al. Among authors: sabatine ms. Nat Med. 2024 Sep;30(9):2641-2647. doi: 10.1038/s41591-024-03188-z. Epub 2024 Aug 6. Nat Med. 2024. PMID: 39107561 Clinical Trial.
Risk of new-onset diabetes and efficacy of pharmacological weight loss therapy.
Moura FA, Bellavia A, Berg DD, Melloni GEM, Feinberg MW, Leiter LA, Bohula EA, Morrow DA, Scirica BA, Wiviott SD, Sabatine MS. Moura FA, et al. Among authors: sabatine ms. Diabetes Obes Metab. 2024 Oct;26(10):4441-4449. doi: 10.1111/dom.15798. Epub 2024 Jul 26. Diabetes Obes Metab. 2024. PMID: 39056220
Effects of dapagliflozin according to QRS duration across the spectrum of left ventricular ejection fraction: An analysis of DAPA-HF and DELIVER.
Abdin A, Kondo T, Böhm M, Jhund PS, Claggett BL, Vaduganathan M, Hernandez AF, Lam CSP, Inzucchi SE, Martinez FA, de Boer RA, Desai AS, Køber L, Sabatine MS, Petersson M, Bachus E, Solomon SD, McMurray JJV;  on behalf of the DAPA‐HF and DELIVER Committees and Investigators. Abdin A, et al. Among authors: sabatine ms. Eur J Heart Fail. 2024 Sep;26(9):1952-1963. doi: 10.1002/ejhf.3350. Epub 2024 Jul 17. Eur J Heart Fail. 2024. PMID: 39016033
Efficacy and safety of SGLT2 inhibitors with and without glucagon-like peptide 1 receptor agonists: a SMART-C collaborative meta-analysis of randomised controlled trials.
Apperloo EM, Neuen BL, Fletcher RA, Jongs N, Anker SD, Bhatt DL, Butler J, Cherney DZI, Herrington WG, Inzucchi SE, Jardine MJ, Liu CC, Mahaffey KW, McGuire DK, McMurray JJV, Neal B, Packer M, Perkovic V, Sabatine MS, Solomon SD, Staplin N, Szarek M, Vaduganathan M, Wanner C, Wheeler DC, Wiviott SD, Zannad F, Heerspink HJL. Apperloo EM, et al. Among authors: sabatine ms. Lancet Diabetes Endocrinol. 2024 Aug;12(8):545-557. doi: 10.1016/S2213-8587(24)00155-4. Epub 2024 Jul 8. Lancet Diabetes Endocrinol. 2024. PMID: 38991584
535 results